213 related items for PubMed ID: 8772625
1. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
J Intern Med; 1996 Mar; 239(3):253-60. PubMed ID: 8772625
[Abstract] [Full Text] [Related]
2. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Chen YJ, Yu WC, Huang JL, Fong AN, Cheng JJ, Chang MS.
Am J Cardiol; 1997 Apr 01; 79(7):905-8. PubMed ID: 9104904
[Abstract] [Full Text] [Related]
3. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
Lau CP, Chow MS, Tse HF, Tang MO, Fan C.
Am J Cardiol; 2000 Dec 15; 86(12):1327-32. PubMed ID: 11113407
[Abstract] [Full Text] [Related]
4. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M, Cullen MT, Casadei G.
Eur Heart J; 1995 Dec 15; 16(12):1943-51. PubMed ID: 8682031
[Abstract] [Full Text] [Related]
5. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E, Denjoy I.
Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
[Abstract] [Full Text] [Related]
6. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
Cardiol J; 2009 Jan 25; 16(6):521-7. PubMed ID: 19950088
[Abstract] [Full Text] [Related]
7. [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial].
Wang AH, Pu JL, Qi XY, Miao WL, Hou ZS, Cong HL, Zhou JZ, Liu XF, Li SM, Han QH, Liu YJ, Yang XC.
Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1677-81. PubMed ID: 21914315
[Abstract] [Full Text] [Related]
8. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
Clin Cardiol; 1996 May 28; 19(5):409-12. PubMed ID: 8723601
[Abstract] [Full Text] [Related]
9. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
[Abstract] [Full Text] [Related]
10. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
Capucci A, Villani GQ, Aschieri D, Piepoli M.
Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
[Abstract] [Full Text] [Related]
11. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S, ERAFT Investigators.
Am J Cardiol; 2002 Dec 15; 90(12):1300-6. PubMed ID: 12480038
[Abstract] [Full Text] [Related]
12. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
Pritchett EL, McCarthy EA, Wilkinson WE.
Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
[Abstract] [Full Text] [Related]
13. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
Di Benedetto S.
Am J Cardiol; 1997 Aug 15; 80(4):518-9. PubMed ID: 9285671
[Abstract] [Full Text] [Related]
14. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
Satullo G, Arrigo F, Cavallaro L, Coglitore A, Fazio F, Saporito F, Sorrenti S, Oreto G.
Minerva Cardioangiol; 1996 Mar 15; 44(3):141-4. PubMed ID: 8767614
[Abstract] [Full Text] [Related]
15. [Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation].
Richiardi E, Gaita F, Greco C, Gaschino G, Comba Costa G, Rosettani E, Brusca A.
Cardiologia; 1992 Feb 15; 37(2):123-7. PubMed ID: 1600529
[Abstract] [Full Text] [Related]
16. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone.
Wolk R, Kulakowski P, Karczmarewicz S, Karpinski G, Makowska E, Czepiel A, Ceremuzynski L.
Int J Cardiol; 1996 Jun 15; 54(3):207-11. PubMed ID: 8818742
[Abstract] [Full Text] [Related]
17. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
Ann Cardiol Angeiol (Paris); 1996 Oct 15; 45(8):469-79. PubMed ID: 8952741
[Abstract] [Full Text] [Related]
18. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
Chimienti M, Cullen MT, Casadei G.
Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
[Abstract] [Full Text] [Related]
19. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
Naccarelli GV, Dorian P, Hohnloser SH, Coumel P.
Am J Cardiol; 1996 Jan 25; 77(3):53A-59A. PubMed ID: 8607392
[Abstract] [Full Text] [Related]
20. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
G Ital Cardiol; 1996 Apr 25; 26(4):379-90. PubMed ID: 8707022
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
